|
|
Our study confirms GABAbR as an autoantigen of paraneoplastic and nonparaneoplastic LE and expands the phenotype of GABAbR antibodies to ataxia, OMS, and status epilepticus. The long-term prognosis is dictated by the presence of a tumor. Recognition of syndromes associated with GABAbR antibodies is important because they usually respond to treatment. |
|